Drug Profile
Research programme: TZAP7 targeted therapeutics - GenPat77
Alternative Names: TZAP7 targeted therapeutics research programme - GenPat77Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GenPat77 Pharmacogenetics
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Transplant-rejection in Germany
- 16 Jul 2016 No recent reports of development identified for research development in Transplant-rejection in USA
- 29 Jun 2005 Early research in Transplant rejection in Germany (unspecified route)